www.analyticsinsight.net

Dec 08, 2004 · Companies with Best Prospects of Success in RNA Interference Drug Trials. ... in Big Pharma Acquisitions of Biotech Companies 50% Increase in Joint Ventures/Alliances Between Big Pharma and Biotech Companies 48% Shrinking Revenue for Big Pharmas 29% Increase in R&D Spending by Big Pharmas 23% Greater Emphasis on Marketing by Big Pharmas 23% All ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.